Current TB therapy requires many months of treatment with complicated medication regimens that tend to cause side effects, often leading to incomplete treatment and poor outcomes. [...]
The breakthrough mRNA technology that underpins the world’s first approved COVID-19 vaccines has now emerged as a critical element of the biopharmaceutical pipeline, extending from cancer [...]
The European Centre for Disease Prevention and Control has issued a risk assessment report regarding the emergence of Hypervirulent Klebsiella pneumoniae ST23 carrying carbapenemase genes in [...]
This study explores the molecular epidemiology of Streptococcus suis, a zoonotic pathogen that has limited documentation in Europe. The researchers utilize molecular techniques to examine strains [...]
Tuberculosis (TB) is a disease caused by Mycobacterium tuberculosis that primarily affects the lungs. It is a global health problem, with nearly 10 million people falling ill with TB and 1.4 [...]
The recent surge in clinical cases of Candida auris in the United States, as highlighted by the CDC study published in the Annals of Internal Medicine, is a cause for concern. The study shows [...]
The emergence of a new strain of gonorrhea in Japan that is resistant to all available antibiotics is a concerning development that has the potential to spread globally. The new strain, HO41, [...]
Two types of fungi, Aspergillus and Candida auris, are becoming harder to treat with the drugs commonly used for such infections. For more information, read here
This just-released report from CDC indicates that antimicrobial-resistant hospital-onset infections and associated deaths have increased significantly since the beginning of the COVID-19 [...]
The director of Spain’s National Center for Microbiology, Jesús Oteo Iglesias, MD, PhD, spoke recently at the Spanish Association of Infectious Diseases and Clinical Microbiology conference [...]
